Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

The Saturday Edition | 2 May 2026
32:14

Afternoon Report | ASX reverses trend
03:42

House prices fall; get ready for higher bread, milk, vege prices; LIV Golf collapse
17:23